Myeloid growth factors should not be administered routinely after allogeneic hematopoietic stem-cell transplantation.
Mehta
Jayesh
J
D016026:Bone Marrow Transplantation; D006085:Graft Survival; D006086:Graft vs Host Disease / Q000209:etiology*; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000601:surgery*; D009503:Neutropenia / Q000517:prevention & control; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000601:surgery*; D012307:Risk Factors; D013921:Thrombocytopenia / Q000209:etiology
D016179:Granulocyte Colony-Stimulating Factor